Articles

DIS3 mutations in multiple myeloma impact the transcriptional signature and clinical outcome

Hematology, Fondazione Cà Granda IRCCS Policlinico, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan
Department of Oncology and Hemato-oncology, University of Milan
Department of Oncology and Hemato-oncology, University of Milan
Myeloma Program, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
Biotechnology Research Unit, Aprigliano, A.O./ASP, Cosenza, Italy; Department of Hematology and Bone Marrow Transplant Unit, Augusta Victoria Hospital, Jerusalem
Hematology, Fondazione Cà Granda IRCCS Policlinico, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan
Hematology, Fondazione Cà Granda IRCCS Policlinico, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan
Hematology, Fondazione Cà Granda IRCCS Policlinico, Milan, Italy; Department of Oncology and Hemato-oncology, University of Milan
Haematologica Early view May 6, 2021 https://doi.org/10.3324/haematol.2021.278342